UK Health Regulators Approve Molnupiravir For Treatment Of COVID-19
November 05, 2021
The Wall Street Journal (11/4, Hopkins, Subscription Publication) reports the UK’s Medicines and Healthcare Products Regulatory Agency approved Merck & Co. and Ridgeback Biotherapeutics’ molnupiravir for the treatment of COVID-19, making it the first to a...